Company Profiles - Medical/Life Sciences Alberta

GERMAN-CANADIAN CENTRE FOR INNOVATION AND RESEARCH
4213 Enterprise Square
10230 Jasper Avenue, Edmonton, Alberta T5J 4P6
Tel: 780-492-4287
Company Profiles - Medical/Life Sciences
Alberta-Germany Collaboration Fund Symposium in Germany October
2012
Calgary Scientific Inc.
CSI’s mandate is to develop medical imaging software and Web and mobile platform
technologies into finished products for clinical use and build the distribution channels
and marketing capability to deliver these products to the global medical marketplace.
CSI has delivered the ResolutionMD suite of advanced visualization products that
combines viewing and image analysis tools with diagnostic assessment tools on both
Web and Mobile device platforms. CSI has obtained FDA, Health Canada and CE Mark
(Europe) approvals to market ResolutionMD and ResolutionMD Mobile. CSI currently
has distribution agreements with several OEM providers in the medical scanner
(CT/MR), PACS (Picture Archival & Communication System) and EMR (Electronic Medical
Records) solutions market. With the development of the PureWeb platform, Calgary
Scientific has extended its reach from medical imaging to the broader IT application
transformation market. Calgary Scientific is a privately-held and investor-funded
company with 70 employees.
They are interested in exploring and potentially developing new partnerships in the
Health IT and ICT enabling technologies sectors.
http://www.calgaryscientific.com/
ChemRoutes Corporation
ChemRoutes Corporation is a private drug discovery technology provider operating at
the interface of organic chemistry, chemical biology, drug discovery and
nanotechnology. They focus on early stage drug discovery to pre-clinical research. Their
proprietary and novel small molecule based scaffolds, building blocks, templates,
chemical arrays and new chemical target research spans infectious, neurodegenerative
and metabolic diseases, pain, inflammation and oncology. They have consistently
delivered results, leading to global partnerships with over 80 pharmaceutical,
agrochemical and biotech companies accessing their novel chemistry driven platforms
for new molecular targets and biochemical pathways.
They are looking to partner in drug discovery & agrochemical research.
http://www.chemroutes.com/
Nanalysis Corp
Nanalysis designs and manufactures point of need analytical products for use across the
entire chemical value chain.
They are building magnetic resonance solutions to fulfill the analytical needs of chemists
and engineers working across a variety of sectors. Their revolutionary products are
miniaturized versions of existing instruments, akin to a personal computer in the age of
mainframes, that bring powerful analytical solutions to the point of need of the
customer. They support development of new chemical entities and nanomaterials and
assist monitoring of environmental regulations and production of biofuels.
Their primary customers are chemical and pharmaceutical industry professionals, major
government and academic organizations, energy and resource industries, and other
professional users in diverse commercial sectors.
http://www.nanalysis.com/
Parvus Therapeutics Inc.
Parvus is a privately held biopharmaceutical company developing and commercializing a
nanotechnology-based therapeutic platform for the treatment of autoimmunity. Their
portfolio of therapeutic candidates, Navacims, have the potential to radically improve
the lives of patients with autoimmune disease. Navacims, are nanoparticles conjugated
to immune system proteins that can be readily modified to target a range of
autoimmune conditions like type I diabetes (T1D), multiple sclerosis and rheumatoid
arthritis, amongst others. Their lead candidate, NavacimTD, is in development for T1D.
The company has passed PoC and is poised to enter clinical development. The Parvus
technology is truly breakthrough and has garnered interest from a variety of potential
industry partners and investors. For example, they have already turned down a
partnership with Pharma in excess of $150M in favor of an alternative route to long
term financial stability -- a venture-backed financing, currently in late due diligence, that
they anticipate closing before the end of 2012.
Parvus uses a low overhead business model and a cadre of global collaborators and
advisors (CRO's, CMO's and advisors, for example), with an emphasis on the US and
Europe. They are looking for additional partners in their area of expertise, for example,
CRO's and CMO's with protein expression and nanoparticle production capabilities
(potentially up to cGMP level). Also, SMEs and research institutes with expertise in novel
animal models of autoimmunity (applicable to MS, Arthritis, Lupus etc.). Finally, via their
founder (academic appointments in both Canada and Spain), they are applying for a FP7
grant and actively looking for SME collaborators in Europe.
http://www.parvustherapeutics.net
Virtual Health Solutions
Providing better in-the-home care and security for People with disabilities and the
elderly. Virtual Health Solutions Inc. (VHSI) provides a web-based advanced security,
safety and health monitoring solution for seniors and the chronically ill. Their VCare
tele-homecare monitoring service allows Clients to receive health care and daily living
monitoring services right in the comfort of their own home – giving them continued
independence well into their senior years. Physicians and other health care providers
can monitor the patient’s health remotely through reviewing weight, blood pressure,
glucose levels and other health indicators that have been provided by the patient online. And safety and security is no longer a major issue as the call centre staff is ready to
respond to any security alarms or medical alerts. VCare gives seniors and the chronically
ill the freedom to live life on their own terms – safely, securely and confidently.
Virtual Health Solutions is especially interested in German organizations designing and
marketing home health medical devices.
http://www.virtualhealthcaresolutions.com/